ロード中...
Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial
BACKGROUND: Sickle cell anemia (SCA) is an inherited hematological disorder that causes a large but neglected global health burden, particularly in Africa. Hydroxyurea represents the only available disease‐modifying therapy for SCA, and has proven safety and efficacy in high‐resource countries. In s...
保存先:
| 出版年: | Pediatr Blood Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825070/ https://ncbi.nlm.nih.gov/pubmed/26275071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25705 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|